Decitabine in combination with idarubicin within a modified busulfan/cyclophosphamide conditioning regimen for patients with advanced myelodysplastic syndrome: A prospective multicenter clinical cohort study.
Chin Med J (Engl)
; 137(9): 1115-1117, 2024 May 05.
Article
in En
| MEDLINE
| ID: mdl-38310445
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Azacitidine
/
Myelodysplastic Syndromes
/
Busulfan
/
Idarubicin
/
Cyclophosphamide
/
Decitabine
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Chin Med J (Engl)
Year:
2024
Document type:
Article